EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Male breast cancer differs from female breast cancer in molecular features that affect prognoses and drug responses

Yangyang Li, Yan Guo, Fengzhi Chen, Yuqing Cui, Xuesong Chen, Guangyue Shi

Translational Oncology · 2024-07 · 45 · 101980

DOI: 10.1016/j.tranon.2024.101980 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Oncology, 2024-07. Verfasst von Yangyang Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang Province 150081, China. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Drug responsesImmunotherapyMale breast cancerPrognosesPropensity score matching

Autor:innen und Institutionen

  • Department of Breast Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang Province 150081, China.
  • Department of Breast Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang Province 150081, China; Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Acad…
  • Department of Oncology, the First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province 150001, China; NHC Key Laboratory of Cell Transplantation, Harbin Medical University, Harbin, Heilongjian…
  • Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang Province 150081, China. Electronic address: sgy2012@126.com.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Li, Y., Guo, Y., Chen, F., Cui, Y., Chen, X., & Shi, G. (2024). Male breast cancer differs from female breast cancer in molecular features that affect prognoses and drug responses. Translational Oncology, 45, 101980. https://doi.org/10.1016/j.tranon.2024.101980

Vancouver

Li Y, Guo Y, Chen F, Cui Y, Chen X, Shi G. Male breast cancer differs from female breast cancer in molecular features that affect prognoses and drug responses. Translational Oncology. 2024;45:101980. doi:10.1016/j.tranon.2024.101980

BibTeX
@article{Li2024,
  author = {Li, Yangyang and Guo, Yan and Chen, Fengzhi and Cui, Yuqing and Chen, Xuesong and Shi, Guangyue},
  title = {Male breast cancer differs from female breast cancer in molecular features that affect prognoses and drug responses},
  journal = {Translational Oncology},
  year = {2024},
  volume = {45},
  pages = {101980},
  doi = {10.1016/j.tranon.2024.101980}
}
Kostenlos starten →